[Summary of our clinical experience with the determination of serum prostate-specific antigen level in the first five years]

Magy Onkol. 2003;47(2):165-8. Epub 2003 Sep 16.
[Article in Hungarian]

Abstract

The authors determined serum PSA levels in combination with digital rectal examination (DRE) and evaluated their role in the differential diagnosis of prostate diseases with special reference to cancer. The possible causes of differences between the observed cut-off level of PSA and the standard level PSA were analyzed. In the last few years the PSA determination found its clinical role in the diagnosis of prostate cancer.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor / blood*
  • Biopsy, Needle
  • Carcinoma / diagnosis*
  • Carcinoma / immunology
  • Carcinoma / pathology
  • Humans
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Prostate-Specific Antigen / blood*
  • Prostatic Hyperplasia / diagnosis
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / immunology
  • Prostatic Neoplasms / pathology
  • Prostatitis / diagnosis
  • Retrospective Studies

Substances

  • Biomarkers, Tumor
  • Prostate-Specific Antigen